TuisORNBV • HEL
add
Orion Oyj Class B
Vorige sluiting
€66,00
Dagwisseling
€65,90 - €68,70
Jaarwisseling
€51,55 - €75,30
Markkapitalisasie
9,70 mjd EUR
Gemiddelde volume
187,24 k
P/V-verhouding
18,25
Dividend-opbrengs
2,62%
Primêre beurs
HEL
Marknuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
| (EUR) | Mrt. 2026info | J/J-verandering |
|---|---|---|
Inkomste | 417,70 m | 17,79% |
Bedryfskoste | 139,30 m | 12,34% |
Netto inkomste | 90,40 m | 47,47% |
Netto winsgrens | 21,64 | 25,16% |
Wins per aandeel | 0,64 | 45,45% |
EBITDA | 130,40 m | 42,67% |
Effektiewe belastingkoers | 20,28% | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
| (EUR) | Mrt. 2026info | J/J-verandering |
|---|---|---|
Kontant en korttermynbeleggings | 199,30 m | -23,17% |
Totale bates | 2,08 mjd | 22,17% |
Totale aanspreeklikheid | 956,70 m | 50,66% |
Totale ekwiteit | 1,12 mjd | — |
Uitstaande aandele | 140,87 m | — |
Prys om te bespreek | 8,28 | — |
Opbrengs op bates | 14,03% | — |
Opbrengs op kapitaal | 18,85% | — |
Kontantvloei
Netto kontantverandering
| (EUR) | Mrt. 2026info | J/J-verandering |
|---|---|---|
Netto inkomste | 90,40 m | 47,47% |
Kontant van bedrywe | 37,00 m | -52,20% |
Kontant van beleggings | -20,30 m | -24,54% |
Kontant van finansiering | 21,70 m | 374,68% |
Netto kontantverandering | 38,40 m | -28,62% |
Beskikbare kontantvloei | 246,21 m | 484,83% |
Meer oor
Orion Corporation, founded in 1917 and headquartered at Espoo, Finland, is a globally operating Finnish company which develops, manufactures and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients for global markets. All of the company's manufacturing sites and the majority of its R&D units are in Finland.
Orion's class A and B shares are listed on the Helsinki Stock Exchange. Wikipedia
HUB
Gestig
21 Sep. 1917
Webwerf
Werknemers
4 132
